Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01443884 · ClinicalTrials.gov registry record · NA
Anti-Inflammatory Activities of Grapes in Humans at Risk for Cardiovascular Disease
A NA study, sponsored by USDA, Western Human Nutrition Research Center.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT01443884: Completed NA study, sponsored by USDA, Western Human Nutrition Research Center.
NCT01443884 is a NA study that has completed, run by USDA, Western Human Nutrition Research Center. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01443884, a NA study, has completed, sponsored by USDA, Western Human Nutrition Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The goal of the study is to determine whether grape consumption can reduce the risk of cardiovascular disease by reducing the presence of inflammatory molecules and positively altering cholesterol levels, lipid profiles, and immune cell responses.
Primary Outcome
C-reactive protein, serum amyloid A, cytokines (IL-1, IL-6, IL-8, and TNF-a), and soluble adhesion molecules (sICAM-1, sVCAM-1) will be measured.
Interventions
- DIETARY_SUPPLEMENT Grape powder, followed by placebo powder
- DIETARY_SUPPLEMENT Placebo powder followed by grape powder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2009-10 |
| Est. Completion | 2011-10 |
| Phase | NA |
What the finished NCT01443884 record still lists
NCT01443884 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Grape powder, followed by placebo powder is the first listed.
NCT01443884 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01443884 about?
NCT01443884 is a clinical study titled "Anti-Inflammatory Activities of Grapes in Humans at Risk for Cardiovascular Disease". The goal of the study is to determine whether grape consumption can reduce the risk of cardiovascular disease by reducing the presence of inflammatory molecules and positively altering cholesterol levels, lipid profiles, and immune cell responses.
What is the current status of trial NCT01443884?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2009-10. Estimated completion is 2011-10.
What interventions are being tested in trial NCT01443884?
The interventions under investigation include: Grape powder, followed by placebo powder (DIETARY_SUPPLEMENT), Placebo powder followed by grape powder (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01443884?
This trial is sponsored by USDA, Western Human Nutrition Research Center, which has 47 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01443884's enrollment target sits among peer trials
24 1736th of 2000 higher than 246 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia